Showing results (1161-1170 of 1,196) with videos related to

Sort By:
Pageof 120
Evidence-Based Complementary and Alternative Medicine : Ecam|December 13, 2021
Using the Symptom Patient Similarity Network to Explore the Difference between the Chinese and Western Medicine Pathways of Ischemic Stroke and its ComorbiditiesLunzhong Zhang, Shu Han, Manli Zhao, et al.
Cell|October 23, 2018
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer TherapyMatthew M Gubin, Ekaterina Esaulova, Jeffrey P Ward, et al.
Gynecologic Oncology|September 12, 2016
In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinomaMariam M AlHilli, Marc A Becker, S John Weroha, et al.
Atherosclerosis|January 14, 2025
Non-culprit plaque healing on serial OCT imaging and future outcome in patients with acute coronary syndromesBoling Yi, Luping He, Dirui Zhang, et al.
Clinical Cardiology|November 30, 2022
Prognostic value of the dynamic hepatorenal function on intermediate-term mortality in TAVI patients with survival to dischargeYijun Yao, Jingjing He, Tianyuan Xiong, et al.
Atherosclerosis|April 8, 2021
Aging-induced isoDGR-modified fibronectin activates monocytic and endothelial cells to promote atherosclerosisJung Eun Park, Gnanasekaran JebaMercy, Kalailingam Pazhanchamy, et al.
Plos One|March 16, 2022
Clinical and analytical validation of FoundationOne®CDx, a comprehensive genomic profiling assay for solid tumorsCoren A Milbury, James Creeden, Wai-Ki Yip, et al.
JACC. Cardiovascular Imaging|January 17, 2023
Clinical Characteristics and Prognosis of MINOCA Caused by Atherosclerotic and Nonatherosclerotic Mechanisms Assessed by OCTMing Zeng, Chen Zhao, Xiaoyi Bao, et al.
Nucleic Acids Research|October 16, 2025
Codon specific readthrough as a mechanism of BRCA2 restoration in acquired PARP inhibitor and chemotherapy resistanceCordelia D McGehee, X Wei Meng, Xinyan Wu, et al.
European Heart Journal|March 7, 2025
Plaque erosion risk and JAK2 V617F variantShengfang Wang, Xing Luo, Sining Hu, et al.
Pageof 120